Cell No. : Cell Name
RCB0486 : CHP-126 update : 2024/12/06 |
||||
Comment | Human cell line derived from Neuroblastoma. N-myc gene is amplified. Application consideration | |||
Comment from the depositor | ||||
Terms and conditions | There is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC. | |||
Remarks | ||||
Order Form | Order Form(C-0005.pdf)   MTA(C-0007.pdf)   MTA(C-0007p.pdf)   | |||
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp). | ||||
Basic information | Depositor | Nishi, Yoshisuke | ||
Originator | Schlesinger, H. R. | |||
Year of deposit | 1990 | |||
Animal | _human < Mammals | |||
Genus | Homo | |||
Species | sapiens | |||
Gender | Female | |||
Age at sampling | 14 months | |||
Tissue | neuroblastoma | |||
Disease name | neuroblastoma (stage III) | |||
Classification | cancer | |||
History | Latt, S. A. | Lifespan | infinite | |
Morphology | other | |||
Cellosaurus(Expasy) | CVCL_1123 | |||
Medium | Medium List | Culture type | Adherent/Suspension cells | |
Culture medium | RPMI1640 + 10% FBS | |||
Antibiotics | Free | Passage method | pipetting or 0.25% Trypsin | Culture information | Passage ratio | 1 : 8 split |
SC frequency | Subculture : once/2-3 weeks, Medium Renewal : 2 times/week | |||
Temperature | 37 ℃ | |||
CO2 concentration | 5 % | |||
Freeze medium | Medium + 10% DMSO | |||
Freezing method | Slow freezing | |||
Mycoplasma/Acholeplasma | (-) | |||
Virus (HIV) | (-) | |||
Isozyme | LD, NP | |||
Chromosome mode | 36-92(50) : /42(2),44(4),45(8),46(29),47(3),50(1)/ | |||
STR(human) | OK | |||
Reference information | Reference | 5 | ||
User's Publication | 1 | |||